Lynn Dudley
Medical · Columbia, MDNPI 1316058084
Payments from drug & device makers
Across 172 payments — averaging $17.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$520
- CSL Behring$382
- Grifols USA, LLC$231
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$166
- Nestle Healthcare Nutrition Inc.$165
- Acella Pharmaceuticals, LLC$155
- plus $1K from 32 others
What the payments were for
- Consulting fees$231%
- Food & beverage$2,98699%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $520 |
| CSL Behring | 19 | $382 |
| Grifols USA, LLC | 12 | $231 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 9 | $166 |
| Nestle Healthcare Nutrition Inc. | 10 | $165 |
| Acella Pharmaceuticals, LLC | 8 | $155 |
| Exact Sciences | 7 | $149 |
| Pfizer | 7 | $123 |
| Novo Nordisk | 6 | $104 |
| Redhill Biopharma Inc. | 6 | $92 |
| Antares Pharma, Inc. | 5 | $89 |
| IBSA Pharma Inc. | 5 | $86 |
| Phadia US Inc. | 3 | $73 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $67 |
| Biohaven Pharmaceutical Holding Company Ltd. | 4 | $58 |
| Aimmune Therapeutics, Inc. | 3 | $56 |
| Lilly USA, LLC | 3 | $55 |
| Paratek Pharmaceuticals, Inc. | 2 | $40 |
| Abbott | 2 | $34 |
| Amarin Pharma, Inc. | 2 | $32 |
| Tolmar, Inc. | 2 | $31 |
| ADMA Biomanufacturing LLC | 1 | $23 |
| Digestive Care, Inc. | 1 | $22 |
| Halozyme Inc | 1 | $21 |
| Radius Health, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| AstraZeneca | 1 | $19 |
| Lundbeck LLC | 1 | $19 |
| Almatica Pharma LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Azurity Pharmaceuticals, Inc. | 1 | $16 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Intra-sana Laboratories | 1 | $14 |
| Merck | 1 | $14 |
| Eisai Inc. | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$3,009 in reported general payments places this provider in the 75th percentile of 543 medical providers in Maryland.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 50 | $2,504 |
| Estradiol (Twice Weekly)Estradiol | 38 | $2,036 |
| Estradiol | 14 | $1,281 |
| DottiEstradiol | 15 | $892 |
| Levothyroxine Sodium | 14 | $208 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $19 | $20814 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 543 medical providers in Maryland.
Other medical in Columbia
- Adam SchmucklerColumbia$17K
- Nina GarciaColumbia$16K
- Jeffrey FrattaliColumbia$8K
- Victoria TrottStevensville$94K
- Sarah SagorskyBaltimore$68K
- Emily GrisnikLeonardtown$62K
- Jennifer HamiltonBel Air$52K
- Kristina TrunnellFrederick$51K
- Karen ScottAnnapolis$49K
- Nicholas WunderAberdeen$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.